1 Study Coverage
1.1 Amifampridine Product Introduction
1.2 Market by Type
1.2.1 Global Amifampridine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Generic
1.2.3 Patent
1.3 Market by Application
1.3.1 Global Amifampridine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Myasthenia Gravis
1.3.3 Potassium Channel Blocker
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amifampridine Sales Estimates and Forecasts 2017-2028
2.2 Global Amifampridine Revenue Estimates and Forecasts 2017-2028
2.3 Global Amifampridine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Amifampridine Sales by Region
2.4.1 Global Amifampridine Sales by Region (2017-2022)
2.4.2 Global Sales Amifampridine by Region (2023-2028)
2.5 Global Amifampridine Revenue by Region
2.5.1 Global Amifampridine Revenue by Region (2017-2022)
2.5.2 Global Amifampridine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Amifampridine Sales by Manufacturers
3.1.1 Global Top Amifampridine Manufacturers by Sales (2017-2022)
3.1.2 Global Amifampridine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Amifampridine in 2021
3.2 Global Amifampridine Revenue by Manufacturers
3.2.1 Global Amifampridine Revenue by Manufacturers (2017-2022)
3.2.2 Global Amifampridine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Amifampridine Revenue in 2021
3.3 Global Amifampridine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Amifampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Amifampridine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Amifampridine Sales by Type
4.1.1 Global Amifampridine Historical Sales by Type (2017-2022)
4.1.2 Global Amifampridine Forecasted Sales by Type (2023-2028)
4.1.3 Global Amifampridine Sales Market Share by Type (2017-2028)
4.2 Global Amifampridine Revenue by Type
4.2.1 Global Amifampridine Historical Revenue by Type (2017-2022)
4.2.2 Global Amifampridine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Amifampridine Revenue Market Share by Type (2017-2028)
4.3 Global Amifampridine Price by Type
4.3.1 Global Amifampridine Price by Type (2017-2022)
4.3.2 Global Amifampridine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Amifampridine Sales by Application
5.1.1 Global Amifampridine Historical Sales by Application (2017-2022)
5.1.2 Global Amifampridine Forecasted Sales by Application (2023-2028)
5.1.3 Global Amifampridine Sales Market Share by Application (2017-2028)
5.2 Global Amifampridine Revenue by Application
5.2.1 Global Amifampridine Historical Revenue by Application (2017-2022)
5.2.2 Global Amifampridine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Amifampridine Revenue Market Share by Application (2017-2028)
5.3 Global Amifampridine Price by Application
5.3.1 Global Amifampridine Price by Application (2017-2022)
5.3.2 Global Amifampridine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Amifampridine Market Size by Type
6.1.1 North America Amifampridine Sales by Type (2017-2028)
6.1.2 North America Amifampridine Revenue by Type (2017-2028)
6.2 North America Amifampridine Market Size by Application
6.2.1 North America Amifampridine Sales by Application (2017-2028)
6.2.2 North America Amifampridine Revenue by Application (2017-2028)
6.3 North America Amifampridine Market Size by Country
6.3.1 North America Amifampridine Sales by Country (2017-2028)
6.3.2 North America Amifampridine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Amifampridine Market Size by Type
7.1.1 Europe Amifampridine Sales by Type (2017-2028)
7.1.2 Europe Amifampridine Revenue by Type (2017-2028)
7.2 Europe Amifampridine Market Size by Application
7.2.1 Europe Amifampridine Sales by Application (2017-2028)
7.2.2 Europe Amifampridine Revenue by Application (2017-2028)
7.3 Europe Amifampridine Market Size by Country
7.3.1 Europe Amifampridine Sales by Country (2017-2028)
7.3.2 Europe Amifampridine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Amifampridine Market Size by Type
8.1.1 Asia Pacific Amifampridine Sales by Type (2017-2028)
8.1.2 Asia Pacific Amifampridine Revenue by Type (2017-2028)
8.2 Asia Pacific Amifampridine Market Size by Application
8.2.1 Asia Pacific Amifampridine Sales by Application (2017-2028)
8.2.2 Asia Pacific Amifampridine Revenue by Application (2017-2028)
8.3 Asia Pacific Amifampridine Market Size by Region
8.3.1 Asia Pacific Amifampridine Sales by Region (2017-2028)
8.3.2 Asia Pacific Amifampridine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Amifampridine Market Size by Type
9.1.1 Latin America Amifampridine Sales by Type (2017-2028)
9.1.2 Latin America Amifampridine Revenue by Type (2017-2028)
9.2 Latin America Amifampridine Market Size by Application
9.2.1 Latin America Amifampridine Sales by Application (2017-2028)
9.2.2 Latin America Amifampridine Revenue by Application (2017-2028)
9.3 Latin America Amifampridine Market Size by Country
9.3.1 Latin America Amifampridine Sales by Country (2017-2028)
9.3.2 Latin America Amifampridine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Amifampridine Market Size by Type
10.1.1 Middle East and Africa Amifampridine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Amifampridine Revenue by Type (2017-2028)
10.2 Middle East and Africa Amifampridine Market Size by Application
10.2.1 Middle East and Africa Amifampridine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Amifampridine Revenue by Application (2017-2028)
10.3 Middle East and Africa Amifampridine Market Size by Country
10.3.1 Middle East and Africa Amifampridine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Amifampridine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Jacobus Pharmaceutical
11.1.1 Jacobus Pharmaceutical Corporation Information
11.1.2 Jacobus Pharmaceutical Overview
11.1.3 Jacobus Pharmaceutical Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Jacobus Pharmaceutical Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Jacobus Pharmaceutical Recent Developments
11.2 Unichem
11.2.1 Unichem Corporation Information
11.2.2 Unichem Overview
11.2.3 Unichem Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Unichem Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Unichem Recent Developments
11.3 BioMarin Pharmaceutical
11.3.1 BioMarin Pharmaceutical Corporation Information
11.3.2 BioMarin Pharmaceutical Overview
11.3.3 BioMarin Pharmaceutical Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BioMarin Pharmaceutical Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BioMarin Pharmaceutical Recent Developments
11.4 Wockhardt
11.4.1 Wockhardt Corporation Information
11.4.2 Wockhardt Overview
11.4.3 Wockhardt Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Wockhardt Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Wockhardt Recent Developments
11.5 Glenmark Pharmaceuticals
11.5.1 Glenmark Pharmaceuticals Corporation Information
11.5.2 Glenmark Pharmaceuticals Overview
11.5.3 Glenmark Pharmaceuticals Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Glenmark Pharmaceuticals Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Glenmark Pharmaceuticals Recent Developments
11.6 Norris Pharm
11.6.1 Norris Pharm Corporation Information
11.6.2 Norris Pharm Overview
11.6.3 Norris Pharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Norris Pharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Norris Pharm Recent Developments
11.7 BLD Pharm
11.7.1 BLD Pharm Corporation Information
11.7.2 BLD Pharm Overview
11.7.3 BLD Pharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 BLD Pharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BLD Pharm Recent Developments
11.8 Biosynth AG
11.8.1 Biosynth AG Corporation Information
11.8.2 Biosynth AG Overview
11.8.3 Biosynth AG Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Biosynth AG Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biosynth AG Recent Developments
11.9 Innovapharm
11.9.1 Innovapharm Corporation Information
11.9.2 Innovapharm Overview
11.9.3 Innovapharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Innovapharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Innovapharm Recent Developments
11.10 Founder Pharma
11.10.1 Founder Pharma Corporation Information
11.10.2 Founder Pharma Overview
11.10.3 Founder Pharma Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Founder Pharma Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Founder Pharma Recent Developments
11.11 BroadPharm
11.11.1 BroadPharm Corporation Information
11.11.2 BroadPharm Overview
11.11.3 BroadPharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 BroadPharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BroadPharm Recent Developments
11.12 CSNpharm
11.12.1 CSNpharm Corporation Information
11.12.2 CSNpharm Overview
11.12.3 CSNpharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CSNpharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CSNpharm Recent Developments
11.13 Merck
11.13.1 Merck Corporation Information
11.13.2 Merck Overview
11.13.3 Merck Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Merck Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Amifampridine Industry Chain Analysis
12.2 Amifampridine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Amifampridine Production Mode & Process
12.4 Amifampridine Sales and Marketing
12.4.1 Amifampridine Sales Channels
12.4.2 Amifampridine Distributors
12.5 Amifampridine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Amifampridine Industry Trends
13.2 Amifampridine Market Drivers
13.3 Amifampridine Market Challenges
13.4 Amifampridine Market Restraints
14 Key Findings in The Global Amifampridine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Amifampridine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Generic
Table 3. Major Manufacturers of Patent
Table 4. Global Amifampridine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Amifampridine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Amifampridine Sales by Region (2017-2022) & (K Units)
Table 7. Global Amifampridine Sales Market Share by Region (2017-2022)
Table 8. Global Amifampridine Sales by Region (2023-2028) & (K Units)
Table 9. Global Amifampridine Sales Market Share by Region (2023-2028)
Table 10. Global Amifampridine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Amifampridine Revenue Market Share by Region (2017-2022)
Table 12. Global Amifampridine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Amifampridine Revenue Market Share by Region (2023-2028)
Table 14. Global Amifampridine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Amifampridine Sales Share by Manufacturers (2017-2022)
Table 16. Global Amifampridine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Amifampridine Revenue Share by Manufacturers (2017-2022)
Table 18. Amifampridine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Amifampridine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Amifampridine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifampridine as of 2021)
Table 21. Amifampridine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Amifampridine Product Offered
Table 23. Date of Manufacturers Enter into Amifampridine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Amifampridine Sales by Type (2017-2022) & (K Units)
Table 26. Global Amifampridine Sales by Type (2023-2028) & (K Units)
Table 27. Global Amifampridine Sales Share by Type (2017-2022)
Table 28. Global Amifampridine Sales Share by Type (2023-2028)
Table 29. Global Amifampridine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Amifampridine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Amifampridine Revenue Share by Type (2017-2022)
Table 32. Global Amifampridine Revenue Share by Type (2023-2028)
Table 33. Amifampridine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Amifampridine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Amifampridine Sales by Application (2017-2022) & (K Units)
Table 36. Global Amifampridine Sales by Application (2023-2028) & (K Units)
Table 37. Global Amifampridine Sales Share by Application (2017-2022)
Table 38. Global Amifampridine Sales Share by Application (2023-2028)
Table 39. Global Amifampridine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Amifampridine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Amifampridine Revenue Share by Application (2017-2022)
Table 42. Global Amifampridine Revenue Share by Application (2023-2028)
Table 43. Amifampridine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Amifampridine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Amifampridine Sales by Type (2017-2022) & (K Units)
Table 46. North America Amifampridine Sales by Type (2023-2028) & (K Units)
Table 47. North America Amifampridine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Amifampridine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Amifampridine Sales by Application (2017-2022) & (K Units)
Table 50. North America Amifampridine Sales by Application (2023-2028) & (K Units)
Table 51. North America Amifampridine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Amifampridine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Amifampridine Sales by Country (2017-2022) & (K Units)
Table 54. North America Amifampridine Sales by Country (2023-2028) & (K Units)
Table 55. North America Amifampridine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Amifampridine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Amifampridine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Amifampridine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Amifampridine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Amifampridine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Amifampridine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Amifampridine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Amifampridine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Amifampridine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Amifampridine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Amifampridine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Amifampridine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Amifampridine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Amifampridine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Amifampridine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Amifampridine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Amifampridine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Amifampridine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Amifampridine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Amifampridine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Amifampridine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Amifampridine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Amifampridine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Amifampridine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Amifampridine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Amifampridine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Amifampridine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Amifampridine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Amifampridine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Amifampridine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Amifampridine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Amifampridine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Amifampridine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Amifampridine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Amifampridine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Amifampridine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Amifampridine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Amifampridine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Amifampridine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Amifampridine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Amifampridine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Amifampridine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Amifampridine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Amifampridine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Amifampridine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Amifampridine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Amifampridine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Amifampridine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Amifampridine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Jacobus Pharmaceutical Corporation Information
Table 106. Jacobus Pharmaceutical Description and Major Businesses
Table 107. Jacobus Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Jacobus Pharmaceutical Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Jacobus Pharmaceutical Recent Developments
Table 110. Unichem Corporation Information
Table 111. Unichem Description and Major Businesses
Table 112. Unichem Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Unichem Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Unichem Recent Developments
Table 115. BioMarin Pharmaceutical Corporation Information
Table 116. BioMarin Pharmaceutical Description and Major Businesses
Table 117. BioMarin Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. BioMarin Pharmaceutical Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. BioMarin Pharmaceutical Recent Developments
Table 120. Wockhardt Corporation Information
Table 121. Wockhardt Description and Major Businesses
Table 122. Wockhardt Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Wockhardt Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Wockhardt Recent Developments
Table 125. Glenmark Pharmaceuticals Corporation Information
Table 126. Glenmark Pharmaceuticals Description and Major Businesses
Table 127. Glenmark Pharmaceuticals Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Glenmark Pharmaceuticals Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Glenmark Pharmaceuticals Recent Developments
Table 130. Norris Pharm Corporation Information
Table 131. Norris Pharm Description and Major Businesses
Table 132. Norris Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Norris Pharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Norris Pharm Recent Developments
Table 135. BLD Pharm Corporation Information
Table 136. BLD Pharm Description and Major Businesses
Table 137. BLD Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. BLD Pharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. BLD Pharm Recent Developments
Table 140. Biosynth AG Corporation Information
Table 141. Biosynth AG Description and Major Businesses
Table 142. Biosynth AG Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Biosynth AG Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Biosynth AG Recent Developments
Table 145. Innovapharm Corporation Information
Table 146. Innovapharm Description and Major Businesses
Table 147. Innovapharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Innovapharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Innovapharm Recent Developments
Table 150. Founder Pharma Corporation Information
Table 151. Founder Pharma Description and Major Businesses
Table 152. Founder Pharma Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Founder Pharma Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Founder Pharma Recent Developments
Table 155. BroadPharm Corporation Information
Table 156. BroadPharm Description and Major Businesses
Table 157. BroadPharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. BroadPharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. BroadPharm Recent Developments
Table 160. CSNpharm Corporation Information
Table 161. CSNpharm Description and Major Businesses
Table 162. CSNpharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. CSNpharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. CSNpharm Recent Developments
Table 165. Merck Corporation Information
Table 166. Merck Description and Major Businesses
Table 167. Merck Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Merck Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Merck Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Amifampridine Distributors List
Table 173. Amifampridine Customers List
Table 174. Amifampridine Market Trends
Table 175. Amifampridine Market Drivers
Table 176. Amifampridine Market Challenges
Table 177. Amifampridine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Amifampridine Product Picture
Figure 3. Global Amifampridine Market Share by Type in 2021 & 2028
Figure 3. Generic Product Picture
Figure 4. Patent Product Picture
Figure 5. Global Amifampridine Market Share by Application in 2021 & 2028
Figure 6. Myasthenia Gravis
Figure 7. Potassium Channel Blocker
Figure 8. Amifampridine Report Years Considered
Figure 9. Global Amifampridine Sales 2017-2028 (K Units)
Figure 10. Global Amifampridine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Amifampridine Revenue 2017-2028 (US$ Million)
Figure 12. Global Amifampridine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Amifampridine Sales Market Share by Region (2017-2022)
Figure 14. Global Amifampridine Sales Market Share by Region (2023-2028)
Figure 15. North America Amifampridine Sales YoY (2017-2028) & (K Units)
Figure 16. North America Amifampridine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Amifampridine Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Amifampridine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Amifampridine Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Amifampridine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Amifampridine Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Amifampridine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Amifampridine Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Amifampridine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Amifampridine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Amifampridine in the World: Market Share by Amifampridine Revenue in 2021
Figure 27. Global Amifampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Amifampridine Sales Market Share by Type (2017-2028)
Figure 29. Global Amifampridine Revenue Market Share by Type (2017-2028)
Figure 30. Global Amifampridine Sales Market Share by Application (2017-2028)
Figure 31. Global Amifampridine Revenue Market Share by Application (2017-2028)
Figure 32. North America Amifampridine Sales Market Share by Type (2017-2028)
Figure 33. North America Amifampridine Revenue Market Share by Type (2017-2028)
Figure 34. North America Amifampridine Sales Market Share by Application (2017-2028)
Figure 35. North America Amifampridine Revenue Market Share by Application (2017-2028)
Figure 36. North America Amifampridine Sales Share by Country (2017-2028)
Figure 37. North America Amifampridine Revenue Share by Country (2017-2028)
Figure 38. United States Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Amifampridine Sales Market Share by Type (2017-2028)
Figure 41. Europe Amifampridine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Amifampridine Sales Market Share by Application (2017-2028)
Figure 43. Europe Amifampridine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Amifampridine Sales Share by Country (2017-2028)
Figure 45. Europe Amifampridine Revenue Share by Country (2017-2028)
Figure 46. Germany Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 47. France Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Amifampridine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Amifampridine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Amifampridine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Amifampridine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Amifampridine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Amifampridine Revenue Share by Region (2017-2028)
Figure 57. China Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 60. India Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Amifampridine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Amifampridine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Amifampridine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Amifampridine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Amifampridine Sales Share by Country (2017-2028)
Figure 71. Latin America Amifampridine Revenue Share by Country (2017-2028)
Figure 72. Mexico Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Amifampridine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Amifampridine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Amifampridine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Amifampridine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Amifampridine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Amifampridine Revenue Share by Country (2017-2028)
Figure 81. Turkey Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Amifampridine Revenue (2017-2028) & (US$ Million)
Figure 84. Amifampridine Value Chain
Figure 85. Amifampridine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
